Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
6,966,028
-
Shares change
-
+524,597
-
Total reported value, excl. options
-
$275,308,091
-
Value change
-
+$16,995,961
-
Put/Call ratio
-
63.17%
-
Number of buys
-
68
-
Number of sells
-
-56
-
Price
-
$39.51
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2015
147 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q3 2015.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,966,028 shares
of 22,278,088 outstanding shares and own 31.27% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (1,056,289 shares), BlackRock Fund Advisors (643,971 shares), STATE STREET CORP (635,023 shares), VANGUARD GROUP INC (341,180 shares), Healthcare Value Capital, LLC (315,000 shares), SENZAR ASSET MANAGEMENT, LLC (270,040 shares), GLENMEDE TRUST CO NA (239,113 shares), WELLS FARGO & COMPANY/MN (235,889 shares), Allianz Asset Management AG (216,141 shares), and BlackRock Institutional Trust Company, N.A. (187,114 shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.